secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0000950170-23-028633
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx shareholders elect directors, ratify PwC, approve say-on-pay at annual meeting
--------------------------------------------------------------------------------

- Elected Julie Bradley, Dipanjan Deb, Stephen LeSieur, and Gregory Mondre as Class III directors with over 3.17B votes for each.
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY 2023 with 3.2B votes for, 217K against.
- Advisory approval of named executive officer compensation received 3.17B votes for, 5.2M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000095017023028633/0000950170-23-028633-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000095017023028633/gdrx-20230614.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-028633

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer